PsyMed Ventures Newsletter

Share this post

DMTweet: a psychedelic tweet recap

psymedventures.substack.com

DMTweet: a psychedelic tweet recap

a PsyMed Ventures x Business Trip colab (issue #5)

PsyMed Ventures
Apr 17, 2022
1
Share this post

DMTweet: a psychedelic tweet recap

psymedventures.substack.com

DMTweet is a newsletter of psychedelic tweets that catch our eye 👀.

This is a collaboration between PsyMed Ventures and Business Trip (yes, we’re the folks working on both 🙃).

Tweets include: Industry updates 💼, Therapy 🛋️, Psychedelic research 🧪, Neuroscience 🧠, Consciousness ✨, Indigenous reciprocity ⚖️, Regulatory updates 📜, and Trippy ideas 👽.

Inclusion = interesting ≠ endorsement.

Let’s get to it….

Twitter avatar for @DKThomp
Derek Thompson @DKThomp
In the last decade, sadness and anxiety has increased for every teenage demographic in every state. The level of sadness is highest for LGBT students, girls, and teens in California. The rate has increased most among white teens, boys, and seniors.
Image
1:25 PM ∙ Apr 11, 2022
419Likes132Retweets
Twitter avatar for @PetrieFlom
Petrie-Flom Center @PetrieFlom
Happening now: A Macro View of Microdosing. Join the conversation using #POPLAR and follow highlights in this 🧵petrieflom.law.harvard.edu/events/details…
petrieflom.law.harvard.eduA Macro View of Microdosing | Events | Petrie-Flom CenterView the conversationon Twitter @PetrieFlom using #POPLAR. We will share the fully captioned recording within 1-2 weeks. Event Description Microdosing psychedel
4:32 PM ∙ Apr 13, 2022
13Likes4Retweets

⬆️ click to read recap of the event ⬆️

Twitter avatar for @PsilocybinAlpha
Psilocybin Alpha @PsilocybinAlpha
BREAKING: Numinus $NUMI to Acquire Novamind $NM, Creating the North American Industry Leader in Psychedelic Therapy and Research
psilocybinalpha.comNuminus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research - Psilocybin AlphaComplementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory Shared mission of…
11:30 AM ∙ Apr 12, 2022
30Likes1Retweet
Twitter avatar for @jomo137
Joe Moore @jomo137
Do you think touch can be helpful in psychedelic assisted psychotherapy? I personally think in some scenarios it can be essential.
2:33 AM ∙ Apr 14, 2022
106Likes3Retweets
Twitter avatar for @MichaelFulwiler
Michael Fulwiler @MichaelFulwiler
75% of people in substance abuse treatment report histories of abuse and trauma, yet most treatment programs don't address underlying trauma. This is a problem.
6:14 PM ∙ Apr 11, 2022
399Likes67Retweets
Twitter avatar for @chrissyfarr
Christina Farr @chrissyfarr
We shouldn’t have universal health care because of wait lists, right? Meanwhile, in America… (A friend just sent me this after attempting to get a psychiatry appointment at UCSF)
Image
11:15 PM ∙ Apr 11, 2022
307Likes68Retweets
Twitter avatar for @sama
Sam Altman @sama
The quality of psychedelic medicine companies (founders, approaches, scientists, etc) has dramatically increased in the past couple of years. Really excited for the impact this is going to have on mental health and happiness; I think it will be a pretty big step forward.
6:08 PM ∙ Apr 7, 2022
989Likes83Retweets
Twitter avatar for @neuroDaws
Richard E. Daws @neuroDaws
Just out in @NatureMedicine. Psilocybin therapy liberates the entrenched depressed brain by increasing the global integration of functional networks. It has been brilliant to collaborate w/ @RCarhartHarris @ProfDavidNutt et al.
nature.comIncreased global integration in the brain after psilocybin therapy for depression - Nature MedicineThe antidepressant response to psilocybin in individuals with treatment-resistant depression is distinct from escitalopram and depends on a global increase in brain network integration.
4:39 PM ∙ Apr 11, 2022
563Likes157Retweets
Twitter avatar for @TechCrunch
TechCrunch @TechCrunch
6 questions investors should ask when evaluating psychedelic biotech companies tcrn.ch/3uRN6IU by @matisere and @kubeans
tcrn.ch6 questions investors should ask when evaluating psychedelic biotech companies – TechCrunchWe believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.
6:20 PM ∙ Apr 6, 2022
20Likes13Retweets

Until next time,

Greg, Matias, and Dina

🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄

DMTweet is a collab between PsyMed Ventures and Business Trip. PsyMed Ventures is a community-focused fund and syndicate investing in psychedelic medicine and mental health tech. Business Trip is a podcast about psychedelic entrepreneurship. Our mission is to help expand access to psychedelic medicine and mental health.

Share this post

DMTweet: a psychedelic tweet recap

psymedventures.substack.com
Comments
TopNewCommunity

No posts

Ready for more?

© 2023 Business Trip
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing